Want to join the conversation?
$TGT 2Q15 PR: In 3Q15, TGT expects adjusted EPS of $0.79-0.89 vs. $0.79 in 3Q14. Company now expects FY15 adjusted EPS of $4.60-4.75 vs. prior guidance of $4.50-4.65. Effective income tax rate from continuing operations was 34.6% vs. 33.7% in 2Q14, driven primarily by the impact on the consolidated tax rate from higher pretax earnings.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.